Notice and Comment on the Draft Revised Excessive Price Guidelines (March 2009)

Brand

• Abbott Laboratories (PDF)
• AstraZeneca (PDF1 / 2)
• Bayer (PDF)
• Eli Lilly Canada Inc. (PDF)
• GlaxoSmithKline (PDF)
• Janssen-Ortho Inc. (PDF)
• LEO Pharma (PDF)
• McNeil Consumer Healthcare (PDF)
• Merck Frosst (PDF)
• Novartis Pharmaceuticals Canada Inc. (PDF)
• Pfizer(PDF)
• Procter & Gamble Pharmaceuticals Canada Inc. (PDF)
• Roche (PDF)
• Rx&D - Canada's Research-Based Pharmaceutical Companies (PDF)
• sanofi-aventis Canada Inc. (PDF)
• Schering-Plough Canada inc. (PDF)
• Servier Canada Inc. (PDF)
• Shire Canada Inc. (PDF)
• Wyeth Pharmaceuticals (PDF)

Biotechnology Industry

• AMGEN (PDF)
• Baxter (PDF)
• BIOTECanada (PDF)

Generics

• CGPA - Canadian Generic Pharmaceutical Association (PDF)

Consumers

• Cumming Jewish Centre for Seniors (PDF)
• Joel Lexchin, MD (PDF1 / 2)

Third Party Payers

• Canadian Life and Health Insurance Association Inc. (PDF)
• Green Shield Canada (PDF)

F/T/P Governments

• British Columbia (PDF)
• Federal Health Care Partnership (PDF)

Others

• Brogan Inc. (PDF)
• Joel Lexchin, MD (PDF1 / 2)
• McKesson Canada (PDF)